Clavulanic acid (Clamentin)
Clavulanic acid
Viatris Healthcare (Pty) Ltd
Registration
- Applicant
- Viatris Healthcare (Pty) Ltd
- Certificate holder
- Viatris Healthcare (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Clamentin 1000 MG EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 875,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 1000 mgFilm-coated tablets | A400088A40/20.1.2/0088Approved 29 May 2025 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Amoxicillin
Consolidated Schedules 06 July 2026, line 5238
S4: Clavulanic acid
Consolidated Schedules 06 July 2026, line 5829
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 5280980.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.